Acurx Pharmaceuticals, Inc.
ACXP · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Sailer Carl: Form 4
Insider disclosure · Filed · Report period 20 Apr 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001736243 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ACXP on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 259 Liberty Avenue, Staten Island, NY, 10305
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Acurx Pharmaceuticals, LLC (to 23 Jun 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields